Produkty 561-65-9

CAS 561-65-9 występuje w naszej ofercie pod nazwami: 18-Hydroxy Corticosterone, 18-Hydroxycorticosterone, 18-HYDROXYCORTICOSTERONE, 97% (CP), 18-Hydroxycorticosterone, 97.00%. Oferty producentów: Chemat Brand, TRC, Biosynth, Sigma-Aldrich, MedChemExpress. Dostępne opakowania: on request, 50mg, 1mg, 1 mg.

18-Hydroxy Corticosterone
Chemat Brand, TRC
  • opakowanie: on request, 50mg
  • Warianty: 2
Zobacz produkt
18-Hydroxycorticosterone
Biosynth
  • opakowanie: 1mg
  • Warianty: 1
Zobacz produkt
18-HYDROXYCORTICOSTERONE, 97% (CP)
Sigma-Aldrich
  • opakowanie: 1MG
  • Warianty: 1
od 7204,00
Zobacz produkt
18-Hydroxycorticosterone, 97.00%
MedChemExpress
  • opakowanie: 1 mg
  • Warianty: 1
od 12979,24
Zobacz produkt

(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 561-65-9) to związek chemiczny o wzorze sumarycznym C21H30O5 i masie molowej 362.5 g/mol. Nazwa systematyczna IUPAC: (8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: HFSXHZZDNDGLQN-ZVIOFETBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O5
Masa molowa362.5 g/mol
Nazwa IUPAC(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-13-(hydroxymethyl)-10-methyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyHFSXHZZDNDGLQN-ZVIOFETBSA-N
SMILESC[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)CO)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 11beta,18,21-trihydroxy-pregn-4-ene-3,20-dione, Pregn-4-ene-3,20-dione, 11,18,21-trihydroxy-, (11beta)-, 18 Hydrocorticosterone, 18-Hydrocorticosterone, Hydroxycorticosterone, 18, 11beta,18,21-Trihydroxypregn-4-ene-3,20-dione, 18-hydroxy corticosterone, Pregn-4-ene-3,20-dione, 11,18,21-trihydroxy-, (11.beta.)-, orb1987440, orb3141074
Izomery (ten sam wzór sumaryczny)
6,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
3,4-dihydroxy-2-(2-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one C21H30O5
(8S,10R,11S,13S)-9,11,12,12-tetradeuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one C21H30O5
2-[[(8R,9S,10S,13S,14S,17S)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-10-yl]methoxy]acetic acid C21H30O5
2-hydroxy-2-[(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]acetic acid C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H30O5
3,5,6-trihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclohexa-2,4-dien-1-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-17-(2,2-dihydroxyacetyl)-11-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(8S,9S,10R,11S,13S,14S,17S)-1,2-dideuterio-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O5
(4R,5S)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one C21H30O5